To evaluate clinical predictors of lymph node invasion (LNI) in patients with high-risk prostate cancer undergoing radical prostatectomy (RP) with extended pelvic lymph node dissection (ePLND).
A contemporary cohort of 116 patients, who underwent ePLND during RP, was retrospectively evaluated.